The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Correction. Forgot to add my 5k shares bought this morning. I have 23k shares to play with on top of my 50k main pot.
Whilst I’m glad the ball is finally rolling on a money raise it is absolutely ludicrous that money was not raised sooner and at a higher price. This is not hindsight people have been saying it for ages. It is also shocking how little the BofD are investing in this potentially life saving raise for SAR. Given the salaries they have drawn over the years they must have been able to put more than a few thousand quid in surely? Or maybe they are content with the million or so shares they already own? Who knows. At least the Company should be around to see the current tests results revealed and the next stage of testing commenced which if good should see some of the damage repaired. At this moment in time just getting back to the long term average of 75p (1.5p old money) would help me breath more easily!!
Not wubbling about one's choices... but when someone posts 'it's been the same scenario for 14 years' they're missing some very and obvious lucrative points in time when the sp jumped 1000% when the HNWIs pushed the price up or the consolidation spike too.
i have sympathy for anyone who thought the sp would never dip below 50p but, again, if one believes the science, even at this distressed price, in months and, definitely, years, this will just be another tale of 'remember when we could buy at 10!' celebration at the buyout... maybe.
Your obviously gifted at purchasing and selling at the right time. Your sarcastic billionaire status remark shows your level especially when it comes to SAR. If you are so good, why do you waste your time on these boards. Surely you would be cruising on a yacht in Dubai or somewhere else nice.
I've traded SAR for 12 years. Sold out completely twice and taken profit via top slicing many times. I've increased my pot by 30% this week and have a record of the buys. If we see a spike on 1a data, I will top slice again. My main pot is 50k shares and I've got around 17k shares on top of that to play with. My SAR shares own me nothing so I'm just playing the game now and have been for 3 years or so.
Most likely the ladder it is invite is at an discount though.
I thought to top up again @10,3 but may have missed the train today.
And, if you really believe in the science then you get closer to 4 x the distessed 50p price and 10x the price when it was comfortably waiting on good news.
miserable for those with mad averages but it wouldn't hurt to sink £1k in at this price and sell at 15-20p before the new shares hit the market!
I've been sitting on that train my choice my money, albeit what's left of it.
You've had the opportunity to multibag your holding numerous times but chose to hold for billionaire status!
i'm amazed that anyone who invests in any company, from Rolls Royce to Sareum doesn't bother to look at a 3 year chart and see the massive discrepancies in the 'value' of a share they hold.
with only a little bit of caution, people could have taken some money off the table to either enjoy profit or reinvest and hold millions more shares!
what is it with people that they sit on the train, waiting for the end of the journey instead of occasionally sightseeing at an intermediate point and hopping back on?
It has been in the same scenario for 14 years. Always close, soon come, next month etc etc and what? A worthless company SP wise for us Long term investors who have averaged down and averaged down again only to be ripped off again. The newbies here might stand a chance of making something but even a 4000% rise from here would would still leave a lot of us way in the red. The science is this and the science is that but the facts are SAR have had our pants down for well over a decade.
Buy *
I wonder if this is the max they can but though Aber - As i say can we buy as many as we want ?
Biotech (and pharma more generally) is a costly business. It takes time and significant resources to get to clinical milestones. Sareun is on the cusp of one such milestone and now has the cash to pursue it. Let the trials complete (says Q2) and the data be presented. If it's as good as we hope then Sareum will be significantly undervalued (imo).
I am a VLTHER but I will not be participating in the placing to assist SAR as I am extremely disappointed that JR is not participating and showing his confidence in the future of SAR given all that we have done for him over the years. The other BOD members have also made feeble placing numbers given their salary increases..... ...JR not participating doe WORRY ME !!!!! and if we do still exist by year end then this is a question for him at the AGM
If I've read things right then 1801 may well be at least equal to Sotyktu, possibly even better.
The RNS noted, "...interim data shows that levels of SDC-1801 in blood are already in the expected therapeutic range, and achieve concentrations greater than those predicted to reduce signalling of cytokines dependent on TYK2 and/or JAK1 activity by 50% for a sustained period following once daily oral dosing."
So what this suggests is akin to a high jumper being able to clear the bar with room to spare. What remains to be seen is just how much higher can 1801 jump?
Sotyktu achieves a reduction of IL-17A, IL-19 and beta-defensin by 47% to 50%, 72%, and 81% to 84% respectively following 16 weeks of once-daily treatment (link below). 1801 appears to be in the 50%+ club so it's all still to play for.
https://www.sotyktuhcp.com/mechanism-of-action
Regards.
Susi, do you have any idea how a junior biotech works? I'd say you don't , based on that post.
It is what it is LTH 's have been shafted and a real shame on P1b / 2a whatever were calling it, but new money has an opportunity now with good P1a results and with the tax credits they are funded through so we have the potential of a license deal just not in the 100s of millions...
£1.5M could last about 4-6 months at best. And as it is very unlikely to have any earnings by then, will they do another fundraise then? Cant see who would support another round of funding. This company is more like a charity, it is dependent on a never ending influx of money from investors gullible enough to constantly give as much money as demanded.
Closes at 12:00 noon on Tuesday 2nd April.
On a Bank Holiday weekend.
Interesting challenge for the brokers.
What is it on the boards part, arrogance, ignorance or confidence that all is going well and we are due spectacular news.
After all that’s gone on with SAR since T2s prediction of 7p (old money) that we would be back here below the .3 (old money) price, news led some to believe we were going to 28p(old money) some even suggested a £. Look at the progress SAR has made with its compounds since then. It’s a crying shame the bod has not mirrored this by steering and keeping us steady alone the way. In fact they have caused a major car crash. Surly all the previous hard work can’t just be in vain. GLA
'... overvalued by 1/3' but you don't say from what price!
i'm still saying 14- 15p today and 40-50p pre news, as long as churn doesn't brake sp too hard.
The placing @ 0.10 suggesting we were overvalued by 1/3.
Placing is nice though anyway.
Guys
Is this so many new shares per your existing holding ?
Blue finish ?
Not far behind you nicely!
Down here £72,943.06 (96.12%) in real money not paper profit!! 😭😭😭😭😭
All we can do now I suppose is wait and hope for a reasonable TO offer post P1a results!
(But even if we get one I'm sure that won't be anywhere near my £2.55 breakeven point! 😒)